The Business Analysts Group, May 2007, Pages: 75
: Consolidated Balance Sheet of all the companies
3: Consolidated Profit and Loss Account of all the companies
InvitrogenCorporation - Competitive Benchmarking Report
Aruvian's R'search, Aug 2010, Pages: 60
is presented in the report which includes a ratio analysis, basic profit and loss analysis, presentation of the company balance sheet, and much more.
A SWOT Framework Analysis of InvitrogenCorporation and its
Bizacumen Inc., Nov 2009, Pages: 488
Discovery Collaborates with Illumina 47
Jubilant & Forest Enter into Partnership Deal 48
InvitrogenCorporation Signs Agreement with Emiliem to Screen
Takeda Pacific, Aug 2010, Pages: 150
This broad and high-level report examines the emerging epigenetics market. This world market includes important biomedical product areas that will have a powerful impact on healthcare delivery
Takeda Pacific, July 2007, Pages: 131
Pharmaceuticals, Inc.
Benitec, Ltd.
Cenix Bioscience GmbH
CytRx Corporation
Dharmacon, Inc.
Integrated DNA Technologies, Inc. (IDT)
Intradigm Corporation
Intronn, Inc.
InvitrogenCorporation
Lentigen Corporation
Research Facts Ltd, March 2009, Pages: 124
Discovery Corporation
Hologic Inc.
Innogenetics NV
Intergenetics, Inc.
InvitrogenCorporation
Ipsogen
Kreatech Holding BV
Matritech, Inc.
Monogram Biosciences, Inc.
Myriad Genetics, Inc.
Nanosphere, Inc.
Nor
Bizacumen Inc., Nov 2009, Pages: 324
Review" by BizAcumen, Inc. Our reports are designed to be most comprehensive in geographic coverage and vertical market analyses. LABORATORY CHEMICAL REAGENTS
NeuroInsights, Oct 2008, Pages: 170
An industry insider report on innovative research and development in stem cell technology for the central nervous system
- Analyzes the scientific approaches and challenges to utilizing stem cells
Best Practices LLC, April 2009, Pages: 43
very quickly. I’ve found that large companies have difficulty adapting in a timely manner.”
This research report examines how leading pharmaceutical companies approach KOL management.
This report
Datamonitor, Jan 2010
relating to income statement, balance sheet, and cash flow statements. .
Scope
- Contains five years data on income statement, balance sheet, cash flows and other financials in the reported currency
Datamonitor, June 2010, Pages: 30
profit of the company was $144.6 million in FY2009, compared t o a net profit of $5.7 million in FY2008.
Scope of the Report
- Provides all the crucial information on Life Technologies Corporation
